Uploaded June 2025 | Updated November 2026, 5 days ago
Martin Mwita was born with sickle cell disease and doctors said he likely wouldn’t live past age 35. But Mwita received a chance for a cure and to live without the excruciating pain that has dominated his young life. With his mother by his side every step of the way throughout his journey, he’s the first patient in the Midwest to receive a revolutionary gene therapy to cure sickle cell disease.
WashU Medicine and St. Louis Children’s Hospital are the first in the Midwest – and among only a few academic centers in the U.S. – to begin offering a newly approved gene therapy to cure sickle cell disease. For more information about sickle cell treatment at WashU Medicine and St. Louis Children’s Hospital, including gene therapy, please call 314-454-KIDS.
8EX89K3IFUOEHD23
PER6QDD4D2788FLF
Martin Mwita was born with sickle cell disease and doctors said he likely wouldn’t live past age 35. But Mwita received a chance for a cure and to live without the excruciating pain that has dominated his young life. With his mother by his side every step of the way throughout his journey, he’s the first patient in the Midwest to receive a revolutionary gene therapy to cure sickle cell disease.
WashU Medicine and St. Louis Children’s Hospital are the first in the Midwest – and among only a few academic centers in the U.S. – to begin offering a newly approved gene therapy to cure sickle cell disease. For more information about sickle cell treatment at WashU Medicine and St. Louis Children’s Hospital, including gene therapy, please call 314-454-KIDS.
8EX89K3IFUOEHD23
PER6QDD4D2788FLF










